ea0099oc2.2 | Oral Communications 2: Calcium and Bone | Part I | ECE2024
Schwarz Peter
, Rejnmark Lars
, Gosmanova Elvira
, Khan Aliya
, Makita Noriko
, Imanishi Yasuo
, Takeuchi Yasuhiro
, Sprague Stuart
, Shoback Dolores M.
, Kohlmeier Lynn
, Rubin Mishaela
, Palermo Andrea
, Gagnon Claudia
, Tsourdi Elena
, Zhao Carol
, Makara Michael
, Ominsky Michael
, Lai Bryant
, Ukena Jenny
, Sibley Christopher
, Shu Aimee
Hypoparathyroidism is an endocrine disease caused by insufficient levels of parathyroid hormone (PTH). Individuals with chronic hypoparathyroidism managed with conventional therapy (active vitamin D and calcium) are at increased risk for renal complications and declines in renal function. In clinical trials, palopegteriparatide treatment enabled independence from conventional therapy (no active vitamin D and ≤600 mg/day elemental calcium) and maintained serum biochemistr...